Latest news with #LinearAccelerator


The Star
26-04-2025
- Health
- The Star
Addressing Malaysia's rising cancer rates
CANCER remains a critical health challenge in Malaysia. This rising trend highlights the urgent need for effective interventions, as experts warn that the incidence of cancer could continue to escalate significantly if proactive measures are not implemented. When it comes to men, lung cancer is the most common type followed by colorectal and prostate cancers. For women, breast cancer is the most widespread, with colorectal and cervical cancers also being major concerns. What is even more worrying is that more cancers are being detected at advanced stages. This shows the urgent need to focus on preventing cancer, early detection and providing better treatments to help improve the lives of those affected. Acting now can make a big difference for the future health of Malaysians. Comprehensive cancer care approach Recognising the need for comprehensive cancer care, Gleneagles Hospitals in Kuala Lumpur, Johor and Kota Kinabalu, which are part of IHH Healthcare Malaysia's network of 18 hospitals, are committed to providing comprehensive cancer care. Each of these hospitals features a dedicated cancer centre equipped with advanced technology for precise diagnosis and personalised treatment options. Over the past five years, these centres have provided care to cancer patients, highlighting the extensive expertise and commitment of these hospitals in addressing the nation's cancer burden. These centres are supported by a team of skilled oncologists, including specialists in clinical oncology, reinforcing the hospitals' commitment to excellence across all aspects of cancer treatment. Gleneagles Hospitals are redefining cancer care through cutting-edge technology, early detection, and patient-centric treatment, striving to improve survival rates and enhance the quality of life for every patient served. Diagnostic tools for early detection Early detection is crucial in cancer care and Gleneagles Hospitals utilise advanced technology to ensure precise and timely diagnosis. The Digital PET-CT with Biograph Vision provides clearer imaging and enhances lesion detection, enabling oncologists to make more informed decisions. Meanwhile, the MRI Fusion Biopsy, which merges MRI with real-time ultrasound, delivers a less invasive and more accurate process for diagnosing conditions such as prostate cancer. Gleneagles Hospitals also offer comprehensive cancer screening programmes to detect common cancers, including breast, colorectal, lung, nasopharyngeal and liver cancers. These assist in early cancer detection, a key factor in improving survival rates and patient outcomes. The Linear Accelerator offers targeted radiotherapy, treating cancer cells effectively while minimising damage to surrounding healthy tissue. Innovative treatment approaches The da Vinci Xi Robotic Surgery system exemplifies the hospital's approach to advanced treatment options. It allows surgeons to perform complex procedures with precision, reducing recovery times and improving patient outcomes. For individuals requiring radiotherapy, Gleneagles Hospitals offer treatment options such as the Linear Accelerator and Gamma Knife Radiosurgery. These precisely target cancer cells while minimising damage to surrounding healthy tissue, providing non-invasive alternatives to traditional surgeries and ensuring faster recovery times. The da Vinci Xi robotic surgery system enables surgeons to perform complex procedures with precision, potentially reducing recovery times and enhancing patient outcomes. Continuing rehabilitative care Rehabilitative care is a crucial part of the holistic care at Gleneagles Hospitals, which supports patients through every stage of their cancer journey. Post-treatment rehabilitation and continuous monitoring improve patients' overall well-being and recovery prospects. Cancer care for the underserved As part of the healthcare provider's mission to reduce the disease burden and make quality healthcare accessible, IHH Healthcare Malaysia has partnered with the Health Ministry to support cancer patients from government hospitals. Through this public-private partnership, cancer patients receive radiotherapy and radiosurgery at Gleneagles Hospitals and other IHH Healthcare Malaysia facilities. Preferred cancer care destination for medical tourists Gleneagles Hospitals are transforming cancer care by combining medical expertise with cutting-edge technology. Their commitment to early detection, personalised treatment and improved patient outcomes establishes them as leaders in oncology and elevates Malaysia as a key destination for medical tourism. Globally recognised, their excellence is certified by the Joint Commission International (JCI) and the Australian Council on Healthcare Standards International (ACHSI) and recognised with prestigious awards such as 'Hospital Group of the Year APAC' and 'Medical Tourism Initiative of the Year - Malaysia' at the Healthcare Asia Awards 2024 and GlobalHealth Asia-Pacific Awards 2024. Additionally, Gleneagles Hospital Kuala Lumpur has been honoured in Newsweek's World's Best Hospitals 2025 rankings, further cementing its reputation for world-class healthcare. Find out more at KKLIU 1332 / EXP 31.12.2027


Times of Oman
26-03-2025
- Health
- Times of Oman
India develops its first indigenous MRI machine, set to be installed at AIIMS
New Delhi: India has developed its first indigenous MRI machine, set to be installed at AIIMS Delhi by October for trials. The move aims to reduce treatment costs and reliance on imported medical devices, as 80-85 per cent of the equipment is currently imported. The indigenous MRI machine will help make India more self-reliant in medical technology. An MoU was also signed between the premier Institute and the Society for Applied Microwave Electronics Engineering and Research (SAMEER), which was set up as an autonomous R & D laboratory at Mumbai under the Department of Electronics, Government of India for the installation of the 1.5 Tesla MRI scanner. According to AIIMS, Delhi Director Dr M Srinivas said that, "majority of equipment in critical care, post operative care, ICU's, robotics, MRI's in India are imported equipment and 80 to 90percent of most of the gadgets high end gadgets are important because we have the best of the brains in the country, and we want to have the best of the equipment of the world also. So this is what ise AIIMS is about. So having got the best of the equipment in the world, we also feel, Can't we do that in India." "Building the nation through the initiatives of India, we feel that, AIIMS is the ideal choice,the best place for us in the country to ,so that we meet the unmet needs and challenges of the country," he said this one step towards Atmanirbhar Bharat. The Ministry of Electronics and Information Technology (MeitY) has spearheaded the development of two critical healthcare technologies the 1.5 Tesla MRI scanner and 6 MEV Linear Accelerator, through the SAMEER as the implementing agency, in collaboration (MRI) with Centre for Development of Advanced Computing (C-DAC), Trivendrum and Kolkata, Inter University Accelerator Centre (IUAC) and Dayanand Sagar Institute (DSI). The MRI scanner is a non-invasive medical imaging test used to visualize soft tissues, while the Linear Accelerator (LINAC) is utilized for cancer treatment using high-energy X-rays or electrons. Both projects have received financial support from MeitY, to make India move towards import substitution.